This is the new registration page for the “Modernizing FDA’s Data Strategy” public meeting that was originally scheduled for March 27, 2020.

-----------------------------------------------------------

**UPDATE (as of 6/9/2020): Modernizing FDA's Data Strategy meeting has now reached full capacity. A recording of the meeting will be available on the meeting webpage here

**UPDATE (as of 5/27/2020): Modernizing FDA's Data Strategy public meeting has been changed to a virtually-only meeting. Registration has been capped at 900 to ensure optimal audio and video quality for AdobeConnect.

ABOUT THE PUBLIC WORKSHOP

The Food and Drug Administration (FDA or the Agency) is announcing a public meeting entitled “Modernizing FDA’s Data Strategy"

FDA is gathering scientific and technical information to help inform the development of FDA’s strategic plan for data. The Agency has determined that a public meeting and an open public docket will encourage public input and engagement in this important topic.

For topics of discussion and information on how to be considered to serve as a presenter and/or panelist, see the Federal Register Notice FDA-2019-N-5799.

ONLINE ATTENDANCE (WEBCAST)

This meeting will be available for online viewing, on the day of the meeting via the following link: Click Here

If you have used Connect Pro before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm.

To get a quick overview of the Connect Pro program, visit https://www.adobe.com/go/connectpro_overview.

MEETING AGENDA

An agenda for the meeting and any other background materials will be made available 5 days before the hearing at Click Here

IMPORTANT MEETING LINKS

FDA Technology Modernization Plan: Click Here

Meeting Website: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/modernizing-fdas-data-strategy-03272020-03272020

Federal Register Notice Website: TBA

EVENT POINT OF CONTACT

Jessica Berrellez, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-0511, Jessica.Berrellez@fda.hhs.gov.

ADDITIONAL INFORMATION

Please Note: The FDA’s collection of information in support of this public meeting is conducted in accordance with the Federal Food, Drug, and Cosmetic Act. FDA is using a third-party service and website, EventBrite, to assist with event registration and collection of information from participants that will be used to frame discussion topics in the meeting. EventBrite is not a government website or application. HHS and FDA privacy policies do not apply to EventBrite. By using EventBrite to communicate with FDA, the information you submit may be accessible to nongovernment third parties. Unless required by law, FDA will not share this information. Furnishing requested information is voluntary. You can alternatively submit information by emailing [insert email address]. When submitting information by website or email, please take care not to submit unnecessary sensitive information such as Social Security number, medical records numbers, and other personal identifiers. Additional detail regarding FDA's use of information is available online:

Privacy Act: Click Here

Website Policies: Click Here